You just read:

Personal Genome Diagnostics' ImmunoSELECT™ Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study

News provided by

Personal Genome Diagnostics Inc.

Jan 04, 2017, 11:49 ET